ReWalk Robotics Logo
IL0011331076
A12BMB
LFWD

ReWalk Robotics

Loading quotes...

Forecast

The analysts' average price target is €8.92 (+67.98%). The median is €8.92 (+67.98%).

Buy
  4
Hold
  0
Sell
  1

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, ReWalk Robotics had revenue of €5.8M and net profit of -€10.09M
(EUR) June 2026
YoY
Revenue 5.8M 19.50%
Gross profit 2.37M 11.42%
Net profit -10.09M 81.29%
EBITDA -9.72M 210.19%

Fundamentals

Metric Value
Market capitalization
€8.56M
Number of shares
1.61M
52-week high/low
€8.58 - €3.69
Dividends No
Beta
0.40
P/E ratio
-0.35
PEG ratio
-0.01
P/B ratio
1.36
P/S ratio
0.44

Company profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Name
ReWalk Robotics
CEO
Joshua Hexter
Headquarters Yokneam Illit, ma
Israel
Website
Sector
Industrials
Industry
Commercial Services & Supplies
IPO
09/12/2014
Employees 81

Ticker symbols

Exchange Symbol
NASDAQ
LFWD
NASDAQ
RWLK
Frankfurt
2RW.F
München
2RW.MU
🍪

Parqet  uses cookies. Learn more